Colorectal cancer (CRC) patients surveyed by 18FDGPET-CT (PET-CT): An open-label multicenter randomized trial (NCT 00624260)

MLA

Isabelle Durand-Zaleski, et al. “Colorectal Cancer (CRC) Patients Surveyed by 18FDGPET-CT (PET-CT): An Open-Label Multicenter Randomized Trial (NCT 00624260).” Journal of Clinical Oncology, vol. 35, May 2017, p. 3520. EBSCOhost, https://doi.org/10.1200/jco.2017.35.15_suppl.3520.

APA

Isabelle Durand-Zaleski, Thierry André, Michel Ducreux, Julien Taieb, Richard Layese, Iradj Sobhani, Thomas Aparicio, Gael Goujon, Christophe Tournigand, Jean Marc Gornet, Pierre Andre Natella, Isabelle Baumgaertner, Emmanuel Itti, Jean-Baptiste Bachet, Alain Luciani, François Hemery, & Sylvie Bastuji Garin. (2017). Colorectal cancer (CRC) patients surveyed by 18FDGPET-CT (PET-CT): An open-label multicenter randomized trial (NCT 00624260). Journal of Clinical Oncology, 35, 3520. https://doi.org/10.1200/jco.2017.35.15_suppl.3520

Chicago

Isabelle Durand-Zaleski, Thierry André, Michel Ducreux, Julien Taieb, Richard Layese, Iradj Sobhani, Thomas Aparicio, et al. 2017. “Colorectal Cancer (CRC) Patients Surveyed by 18FDGPET-CT (PET-CT): An Open-Label Multicenter Randomized Trial (NCT 00624260).” Journal of Clinical Oncology 35 (May): 3520. doi:10.1200/jco.2017.35.15_suppl.3520.